ASTELLAS PHARMA INC

This company is engaged in manufacturing, marketing and importing/exporting of pharmaceuticals and related products. The company was formed through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd in April 2005. It conducts business from its registered head office which is strategically located in Tokyo, Japan. The company contributes to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The company is targeting urology, immunology and inflammation, diabetes, central nervous system and pain, infectious diseases including viruses and cancer. Its major research laboratories in Japan are located in Tsukuba and Osaka and development bases are integrated in Tokyo. Clinical development is the primary focus of overseas operations, with a North American center in Illinois, and a European center in the Netherlands, with additional facilities in Germany. With one of the largest sales forces in Japan, it is further strengthening its marketing organization to consolidate its number one position in both quality and quantity in the domestic ethical drug market. It aims to establish competitive advantages in selected therapeutic areas, carrying a wide spectrum of products with sizable sales in each field. In Japan, mainstay products areas include: urology (Vesicare and Harnal), transplants and immunology (Prograf, Protopic and Intal), cardiovascular (Lipitor, Micardis, Dorner), gastrointestinal organs (Gaster), infection diseases (Fubguard, Targosid and Cefzon), and psychiatry (Myslee, Luvox and Seroquel). It is cementing its presence as an R&D driven global pharmaceutical company by further expanding its R&D, production, and marketing organizations in the U.S., the world's largest pharmaceutical market, as well as in major countries in Europe and Asia. In the US market, the company is achieving sustained growth in the transplants, cardiovascular, dermatology, infectious diseases and urology fields. In Europe, it also carries out R&D, manufacturing, and marketing. Its European headquarters in United Kingdom oversees the whole of Europe with its nineteen sales subsidiaries. In fast-growing Asian markets (China, Southeast Asia), it has already established marketing and production functions in China and marketing functions in Korea and Taiwan.